- Home
- EPM vs STTK Comparison
EPM vs STTK Comparison
Compare EPM & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- STTK
- Stock Information
- Founded
- EPM 2003
- STTK 2016
- Country
- EPM United States
- STTK United States
- Employees
- EPM N/A
- STTK N/A
- Industry
- EPM Oil & Gas Production
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- STTK Health Care
- Exchange
- EPM Nasdaq
- STTK Nasdaq
- Market Cap
- EPM 164.3M
- STTK 37.6M
- IPO Year
- EPM 1996
- STTK 2020
- Fundamental
- Price
- EPM $4.79
- STTK $0.79
- Analyst Decision
- EPM Hold
- STTK Hold
- Analyst Count
- EPM 1
- STTK 4
- Target Price
- EPM $4.50
- STTK $3.00
- AVG Volume (30 Days)
- EPM 201.1K
- STTK 385.8K
- Earning Date
- EPM 05-13-2025
- STTK 07-31-2025
- Dividend Yield
- EPM 10.11%
- STTK N/A
- EPS Growth
- EPM N/A
- STTK N/A
- EPS
- EPM N/A
- STTK N/A
- Revenue
- EPM $85,959,000.00
- STTK $4,606,000.00
- Revenue This Year
- EPM $2.62
- STTK N/A
- Revenue Next Year
- EPM $4.53
- STTK N/A
- P/E Ratio
- EPM N/A
- STTK N/A
- Revenue Growth
- EPM 3.79
- STTK 69.65
- 52 Week Low
- EPM $4.05
- STTK $0.69
- 52 Week High
- EPM $6.14
- STTK $4.99
- Technical
- Relative Strength Index (RSI)
- EPM 52.02
- STTK 38.78
- Support Level
- EPM $4.64
- STTK $0.85
- Resistance Level
- EPM $5.08
- STTK $1.14
- Average True Range (ATR)
- EPM 0.14
- STTK 0.08
- MACD
- EPM -0.04
- STTK -0.02
- Stochastic Oscillator
- EPM 26.32
- STTK 1.60
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the United States. It is engaged predominantly in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are generated from its crude oil, natural gas, and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.